nach oben

Polymer Bulletin

Erschienen in:

28.12.2022 | REVIEW PAPER

Exploring the advancement of polymer-based nano-formulations for ocular drug delivery systems: an explicative review

verfasst von: Moumoyee Chakraborty, Debarya Banerjee, Swarupananda Mukherjee, Dipanjan Karati

Erschienen in: Polymer Bulletin | Ausgabe 11/2023

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The delivery of drugs to different parts of the eye through conventional approaches has been a troublesome task for years, and the urge to overcome the disadvantages of these formulations leads to the discovery of nanosized particle-based ocular formulations that are provided with numerous advantages over the previous attempts. Medical applications of nanotechnology, from disease diagnosis to treatment, have been extensively studied. Nanosuspensions, Several Nanoparticles, Nanomicelles, Nanowafers, and Microemulsions, etc., are supplied with several benefits like improved bioavailability, ease of delivery, help the patients to comply with the dosing regimen, and reach sufficient concentration at the action site. Biodegradable polymers provide enhanced retention time, increased bioavailability, and regulated release through mucoadhesion to the epithelia in the eye, among other advantageous qualities. This review emphasizes on the different nano-formulations applied to the field of pharmacy for successful delivery of ophthalmic preparations.

Graphical abstract

Nanotherapeutics for Ocular Drug Delivery System

Vorheriger Artikel Influence of phytochemicals with iron oxide nanoparticles for biomedical applications: a review

Nächster Artikel Preparation of novel PMMA-NaNbO3-carbon quantum dot composite films for studies of dielectric properties and a.c. conductivity studies

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

WHO (2018) https://www.who.int/blindness/causes/priority/en/ index1.html

Cholkar K, Dasari SR, Pal D, Mitra AK (2013) Eye: anatomy, physiology and barriers to drug delivery. InOcular transporters and receptors. Woodhead publishing; 1–36. https://doi.org/10.1533/9781908818317.1.

Jacob S, Nair AB, Shah J (2020) Biomater. Emerging role of nanosuspensions in drug delivery systems. Biomater Res 24:3. https://doi.org/10.1186/s40824-020-0184-8CrossRefPubMedPubMedCentral

Patravale VB, Date AA, Kulkarni RM (2004) Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56:827–840PubMed

Jiraporn C, Walailak J (2007) Nanosuspension technology for drug delivery. Walailak J Sci Tech 4(2):139–153

Ali HSM, York P, Ali AMA, Blagden N (2011) Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet milling. J Control Release 149:175–181. https://doi.org/10.1016/j.jconrel.2010.10.007CrossRefPubMed

Kassem M, Rahman AA, Ghorab MM, Ahmed MB, Khalil RM (2007) Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm 340:126–133PubMed

Kamaleddin MA (2017) Nano-ophthalmology: applications and considerations. Nanomedicine 13:1459–1472PubMed

Vandamme TF (2002) Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 21(1):15–34. https://doi.org/10.1016/s1350-9462(01)00017-9CrossRefPubMed

10.

Lawrence MJ et al (2000) Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv 45:89–121

11.

Kalam MA, Alshamsan A, Aljuffali IA, Mishra AK, Sultana Y (2016) Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination. Drug Deliv 23:896–907. https://doi.org/10.3109/10717544.2014.920432CrossRefPubMed

12.

Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R et al (2003) Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci 44:3562–3569PubMed

13.

Varshochian R, Riazi-Esfahani M, Jeddi-Tehrani M et al (2015) Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res A 103:3148–3156. https://doi.org/10.1002/jbm.a.35446CrossRefPubMed

14.

Rehman AU, Akram S, Seralin A, Vandamme T, Anton N (2020) Lipid nanocarriers: formulation, properties, and applications. In: Smart nanocontainers; Elsevier: Amsterdam, The Netherlands, 355–382

15.

Asasutjarit R, Managit C, Phanaksri T, Treesuppharat W, Fuongfuchat A (2020) Formulation development and in vitro evaluation of transferrin-conjugated liposomes as a carrier of ganciclovir targeting the retina. Int J Pharm 577:119084PubMed

16.

Hwang JY, Li Z, Loh XJ (2016) Small molecule therapeutic-loaded liposomes as therapeutic carriers: from development to clinical applications. RSC Adv 6:70592–70615

17.

Ebrahim S, Peyman GA, Lee PJ (2005) Applications of liposomes in ophthalmology. Surv Ophthalmol 50:167–182. https://doi.org/10.1016/j.survophthal.2004.12.006CrossRefPubMed

18.

Grimaudo MA, Pescina S, Padula C et al (2018) Poloxamer 407/TPGS Mixed micelles as promising carriers for cyclosporine ocular delivery. Mol Pharm 15:571–584. https://doi.org/10.1021/acs.molpharmaceut.7b00939CrossRefPubMed

19.

Wu W, He Z, Zhang Z, Yu X, Song Z, Li X (2016) Intravitreal injection of rapamycin-loaded polymeric micelles for inhibition of ocular inflammation in rat model. Int J Pharm 513:238–246. https://doi.org/10.1016/j.ijpharm.2016.09.013CrossRefPubMed

20.

Ahmad I, Pandit J, Sultana Y, Mishra AK, Hazari PP, Aqil M (2019) Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: characterization, pharmacokinetic and deposition study. Mater Sci Eng, C 100:959–970

21.

Reimondez-Troitiño S, Csaba N, Alonso MJ, Fuente M (2015) Nanotherapies for the treatment of ocular diseases. Eur J Pharm Biopharm 95:279–293PubMed

22.

Herrero-Vanrell R, Torre VDL, Andres-Guerrero V, Barbosa-Alfaro D, Molina-Martinez IT, Bravo-Osuna I (2013) Nano and microtechnologies for ophthalmic administration, an overview. J Drug Deliv Sci Technol 23:75–102

23.

Ge X, Wei M, He S, Yuan WE (2019) Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics 11:55PubMedPubMedCentral

24.

Kaur IP, Garg A, Singla AK, Aggarwal D (2004) Vesicular systems in ocular drug delivery: an overview. Int J Pharm 269:1–14PubMed

25.

Chen S, Hanning S, Falconer J, Locke M, Wen J (2019) Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm 144:18–39PubMed

26.

Gugleva V, Titeva S, Rangelov S, Momekova D (2019) Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system. Int J Pharm 567:118431PubMed

27.

Zeng W, Li Q, Wan T, Liu C, Pan W, Wu Z et al (2016) Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf B Biointerfaces 141:28–35PubMed

28.

Wang F, Bao X, Fang A et al (2018) Nanoliposome-encapsulated brinzolamide-hydropropyl-beta-cyclodextrin inclusion complex: a potential therapeutic ocular drug-delivery system. Front Pharmacol 9:91. https://doi.org/10.3389/fphar.2018.00091CrossRefPubMedPubMedCentral

29.

Soliman OA, Mohamed EA, Khatera NA (2019) Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro–in vivo evaluation. Pharm Dev Technol 24(1):48–62PubMed

30.

Yandrapu SK, Upadhyay AK, Petrash JM, Kompella UB (2013) Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab. Mol Pharm 10:4676–4686. https://doi.org/10.1021/mp400487fCrossRefPubMed

31.

Mehra N, Aqil M, Sultana Y (2021) A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and stability study. Eur J Pharm Sci 159:105735. https://doi.org/10.1016/j.ejps.2021.105735CrossRefPubMed

32.

Peterson GI (2017) Biodegradable shape memory polymers in medicine. Adv Healthc Mater 6:1700694

33.

Karati D (2022) A concise review on bio-responsive polymers in targeted drug delivery system. Polym Bull. https://doi.org/10.1007/s00289-022-04424-7CrossRef

34.

Gai X, Cheng L, Li T et al (2018) In vitro and in vivo studies on a novel bioadhesive colloidal system: cationic liposomes of ibuprofen. AAPS Pharm Sci Tech 19:700–709. https://doi.org/10.1208/s12249-017-0872-4CrossRef

35.

Garg V, Suri R, Jain GK, Kohli K (2017) Proglycosomes: a novel nano-vesicle for ocular delivery of tacrolimus. Colloids Surf B Biointerfaces 157:40–47. https://doi.org/10.1016/j.colsurfb.2017.05.049CrossRefPubMed

36.

Nagai N, Ishii M, Seiriki R et al (2020) Novel sustained-release drug delivery system for dry eye therapy by rebamipide nanoparticles. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12020155CrossRefPubMedPubMedCentral

37.

Orasugh JT, Sarkar G, Saha NR, Das B, Bhattacharyya A, Das S, Mishra R, Roy I, Chattoapadhyay A, Ghosh SK, Chattopadhyay D (2019) Effect of cellulose nanocrystals on the performance of drug loaded in situ gelling thermo-responsive ophthalmic formulations. Int J Biol Macromol 124:235–245PubMed

38.

Bawa P, Pillay V, Choonara YE, du Toit LC (2009) Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater 4:022001PubMed

39.

Irimia T, Ghica MV, Popa L, Anuta V, Arsene AL, Dinu-Pirvu CE (2018) Strategies for improving ocular drug bioavailability and corneal wound healing with chitosan-based delivery systems. Polymers 10:1221PubMedPubMedCentral

40.

Yeh TH, Hsu LW, Tseng MT, Lee PL, Sonjae K, Ho YC et al (2011) Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials 32:6164–6173PubMed

41.

Fischak C, Klaus R, Werkmeister RM, Hohenadl C, Prinz M, Schmettere L et al (2017) Effect of topically administered chitosan-N-acetylcysteine on cornal wound healing in a rabbit model. J Ophthalmol 2017:1–6

42.

Lynch C, Kondiah PPD, Choonara YE, Toit LCD, Ally N, Pillay V (2019) Advances in biodegradable nano-sized polymer-based ocular drug delivery. Polymers 11:1371PubMedPubMedCentral

43.

Bongiovi F (2017) Hyaluronic acid-based micelles as ocular platform to modulate the loading, release and corneal permeation of corticosteroids. Macromol Biosci 17:1700261

44.

Widjaja LK, Bora M, Chan PNPH, Lipik V, Wong TTL, Venkatraman SS (2013) Hyaluronic acid-based nanocomposites hydrogels for ocular drug delivery applications. J Biomed Mater Res 102:3056–3065

45.

Costa JR, Silva NC, Sarmento B, Pintado M (2015) Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin. Eur J Clin Microbiol Infect Dis 34:1255–1262PubMed

46.

Jain D, Carvalho E, Banerjee R (2010) Biodegradable hybrid polymeric membranes for ocular drug delivery. Acta Biomater 6:1370–1379PubMed

47.

Vasconcelos A, Vega E, Perez Y, Gomara MJ, Garcia ML, Haro I (2015) Conjugation of cell-penetrating peptides with poly (lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery. Int J Nanomed 10:609–631

48.

Tahara K, Karasawa K, Onodera R, Takeuchi H (2017) Feasibility of drug delivery to the eye’s posterior segment by topical instillation of PLGA nanoparticles. Asian J Pharm Sci 12:394–399PubMedPubMedCentral

49.

Sun S, Li J, Li X, Lan B, Zhou S, Meng Y, Cheng L (2016) Episcleral drug film for better-targeted ocular drug delivery and controlled release using multi-layered poly-ε-caprolactone. Acta Biomater 37:143–154PubMed

50.

Mir M, Ahmed N, Rehman AU (2017) Recent applications of PLGA based nanostructures in drug delivery. Colloids Surf B Biointerfaces 159:217–231PubMed

51.

Narang AS, Chang RK, Hussain MA (2013) Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems. J Pharm Sci 102:3867–3882PubMed

52.

Agrahari V, Hiremath P (2017) Challenges associated and approaches for successful translation of nanomedicines into commercial products. Nanomedicine 12:819–823PubMed

53.

Gorantla S, Rapallia VK, Waghule T, Singh PP, Dubey SK, Saha RN (2020) Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv 10:27835–27855PubMedPubMedCentral

54.

Colombo AP, Briançon S, Lieto J, Fessi H (2001) Project, design, and use of a pilot plant for nanocapsule production. Drug Dev Ind Pharm 27(10):1063–1072PubMed

55.

Patil H, Tiwari RV, Repka MA (2016) Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech 17(1):20–42PubMed

56.

Jafari SM, Assadpoor E, He Y, Bhandari B (2008) Re-coalescence of emulsion droplets during high-energy emulsification. Food Hydrocoll 22(7):1191–1202

57.

Jenning V, Lippacher A, Gohla SH (2002) Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization. J Microencapsul 19(1):10

58.

Fàbregas A, Miñarro M, García-Montoya E, Pérez-Lozano P, Carrillo C, Sarrate R, Sánchez N, Ticó JR, Suñé-Negre JM (2013) Impact of physical parameters on particle size and reaction yield when using the ionic gelation method to obtain cationic polymeric chitosan–tripolyphosphate nanoparticles. Int J Pharm 446(1–2):199–204PubMed

59.

Merkela TJ, Chena K, Jones SW, Pandyaa AA, Tianag S, Napier ME (2012) The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. J Control Releas 162(1):37–44

60.

Acharya G, Shin CS, McDermott M, Mishra H, Park H, Kwon IC, Park K (2010) The hydrogel template method for fabrication of homogeneous nano/microparticles. J Control Releas 141(3):314–319

61.

Meng T, Kulkarni V, Simmers R, Brar V, Xu Q (2019) Therapeutic implications of nanomedicine for ocular drug delivery. Drug Discov Today 24(8):1524–1538PubMedPubMedCentral

62.

Safety and efficacy of liposomal latanoprost in ocular hypertension—Full Text View—ClinicalTrials.gov, https://www.clinicaltrials.gov/ct2/show/NCT01987323, Accessed 29 July 2019.

63.

Paclitaxel albumin-stabilized nanoparticle formulation in treating patients with metastatic melanoma of the eye that cannot be removed by surgery—Full Text View—ClinicalTrials.gov, https://www.clinicaltrials.gov/ct2/show/NCT00738361, Accessed 31 July 2019

64.

A Randomized Controlled Trial Comparing Urea Loaded Nanoparticles to Placebo: a New Concept for Cataract Management–Full Text View—ClinicalTrials.gov, https://www.clinicaltrials.gov/ct2/show/NCT03001466, Accessed 29 July 2019

65.

Search of: NCT03785340—List Results—ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT03785340. Accessed 28 Mar 2020

66.

A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AXR-159 Ophthalmic Solution in Patients with Dry Eye Disease (DED) - Full Text View—ClinicalTrials.gov, https://www.clinicaltrials.gov/ct2/show/NCT03598699, Accessed 28 Mar 2020.

67.

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects with Neovascular (Wet) Age-related Macular Degeneration—Full Text View—ClinicalTrials.gov, https://www.clinicaltrials.gov/ct2/show/NCT03249740, Accessed 28 Mar 2020

68.

Study Assessing AR-1105 in Subjects with Macular Edema Due to Retinal Vein Occlusion (RVO)—Full Text View—ClinicalTrials.gov, https://www.clinicaltrials.gov/ct2/show/NCT03739593, Accessed 28 Mar 2020

69.

Tian R, Sharma A, Nozari A, Subramaniam R, Lundstedt T, Sharma S (2012) Nanowired drug delivery to enhance neuroprotection in spinal cord injury. CNS Neurol Disord Drug Targets 11:85–95

70.

Patra JK, Das G, Fracet LF, Campos EVR, Rodriques-Torres M, Acosta-Torres LS et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16:71

71.

Bhardwaj A, Arora R (2018) Nanoformulations: a novel approach against hypoxia. Emerg Nanotechnol. 231–256

Titel: Exploring the advancement of polymer-based nano-formulations for ocular drug delivery systems: an explicative review
verfasst von: Moumoyee Chakraborty
Debarya Banerjee
Swarupananda Mukherjee
Dipanjan Karati
Publikationsdatum: 28.12.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Polymer Bulletin / Ausgabe 11/2023
Print ISSN: 0170-0839
Elektronische ISSN: 1436-2449
DOI: https://doi.org/10.1007/s00289-022-04661-w

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht

Springer Professional

Abstract

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Weitere Artikel der Ausgabe 11/2023

Research progress on chemical modification of waste biomass cellulose to prepare heavy metal adsorbents

Urethane- and urea-modified polymeric sorbents enable efficient and selective removal of mercury(II) from water

Effect of the amine and carboxyl functionalised graphene on the thermomechanical and interfacial properties of the shape memory polymer nanocomposites

Optimization of catalyst content for recycled polyethylene terephthalate (PET) and polycarbonate (PC) blending

Design of acetylene-modified bio-based tri-functional benzoxazine and its copolymerization with bismaleimide for performance enhancement

Broadband dielectric dispersion (20 Hz–1 GHz) and relaxation, crystalline structure, and thermal characterization of PVDF/PMMA blend films

Premium Partner

Marktübersichten